nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—appendage—restless legs syndrome	0.0793	0.105	CbGeAlD
Ponatinib—RET—autonomic nervous system—restless legs syndrome	0.0688	0.0913	CbGeAlD
Ponatinib—Nilotinib—MAP2K5—restless legs syndrome	0.066	1	CrCbGaD
Ponatinib—KDR—hindlimb—restless legs syndrome	0.0474	0.0629	CbGeAlD
Ponatinib—KDR—appendage—restless legs syndrome	0.0407	0.0539	CbGeAlD
Ponatinib—FGFR4—brainstem—restless legs syndrome	0.0354	0.0469	CbGeAlD
Ponatinib—FGFR4—nervous system—restless legs syndrome	0.0185	0.0246	CbGeAlD
Ponatinib—FGFR4—central nervous system—restless legs syndrome	0.0178	0.0237	CbGeAlD
Ponatinib—FGFR2—brainstem—restless legs syndrome	0.0158	0.0209	CbGeAlD
Ponatinib—FGFR3—spinal cord—restless legs syndrome	0.015	0.0199	CbGeAlD
Ponatinib—FGFR4—brain—restless legs syndrome	0.0142	0.0188	CbGeAlD
Ponatinib—BCR—spinal cord—restless legs syndrome	0.013	0.0172	CbGeAlD
Ponatinib—LYN—nervous system—restless legs syndrome	0.0127	0.0169	CbGeAlD
Ponatinib—FGFR3—nervous system—restless legs syndrome	0.0126	0.0168	CbGeAlD
Ponatinib—LYN—central nervous system—restless legs syndrome	0.0122	0.0162	CbGeAlD
Ponatinib—FGFR3—central nervous system—restless legs syndrome	0.0122	0.0161	CbGeAlD
Ponatinib—FGFR1—spinal cord—restless legs syndrome	0.0115	0.0153	CbGeAlD
Ponatinib—KIT—brainstem—restless legs syndrome	0.011	0.0145	CbGeAlD
Ponatinib—BCR—nervous system—restless legs syndrome	0.0109	0.0145	CbGeAlD
Ponatinib—BCR—central nervous system—restless legs syndrome	0.0105	0.014	CbGeAlD
Ponatinib—RET—spinal cord—restless legs syndrome	0.0103	0.0137	CbGeAlD
Ponatinib—FGFR2—spinal cord—restless legs syndrome	0.00982	0.013	CbGeAlD
Ponatinib—LYN—brain—restless legs syndrome	0.00971	0.0129	CbGeAlD
Ponatinib—FGFR3—brain—restless legs syndrome	0.00966	0.0128	CbGeAlD
Ponatinib—ABL1—brainstem—restless legs syndrome	0.00954	0.0127	CbGeAlD
Ponatinib—TEK—spinal cord—restless legs syndrome	0.00941	0.0125	CbGeAlD
Ponatinib—FGFR4—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.00901	0.05	CbGpPWpGaD
Ponatinib—RET—nervous system—restless legs syndrome	0.00871	0.0115	CbGeAlD
Ponatinib—FGFR2—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00863	0.0479	CbGpPWpGaD
Ponatinib—PDGFRA—spinal cord—restless legs syndrome	0.00853	0.0113	CbGeAlD
Ponatinib—RET—central nervous system—restless legs syndrome	0.00838	0.0111	CbGeAlD
Ponatinib—SRC—spinal cord—restless legs syndrome	0.00836	0.0111	CbGeAlD
Ponatinib—BCR—brain—restless legs syndrome	0.00836	0.0111	CbGeAlD
Ponatinib—FGFR2—nervous system—restless legs syndrome	0.00827	0.011	CbGeAlD
Ponatinib—FGFR2—central nervous system—restless legs syndrome	0.00796	0.0106	CbGeAlD
Ponatinib—TEK—nervous system—restless legs syndrome	0.00793	0.0105	CbGeAlD
Ponatinib—FGFR2—Ectoderm Differentiation—TOX3—restless legs syndrome	0.00787	0.0437	CbGpPWpGaD
Ponatinib—KDR—spinal cord—restless legs syndrome	0.00769	0.0102	CbGeAlD
Ponatinib—TEK—central nervous system—restless legs syndrome	0.00764	0.0101	CbGeAlD
Ponatinib—FGFR1—brain—restless legs syndrome	0.00744	0.00986	CbGeAlD
Ponatinib—PDGFRA—nervous system—restless legs syndrome	0.00719	0.00953	CbGeAlD
Ponatinib—SRC—nervous system—restless legs syndrome	0.00705	0.00935	CbGeAlD
Ponatinib—PDGFRA—central nervous system—restless legs syndrome	0.00692	0.00918	CbGeAlD
Ponatinib—KIT—spinal cord—restless legs syndrome	0.00682	0.00904	CbGeAlD
Ponatinib—SRC—central nervous system—restless legs syndrome	0.00678	0.009	CbGeAlD
Ponatinib—FGFR3—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.00667	0.037	CbGpPWpGaD
Ponatinib—RET—brain—restless legs syndrome	0.00666	0.00883	CbGeAlD
Ponatinib—KDR—nervous system—restless legs syndrome	0.00648	0.0086	CbGeAlD
Ponatinib—FGFR2—brain—restless legs syndrome	0.00632	0.00839	CbGeAlD
Ponatinib—FGFR2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00627	0.0348	CbGpPWpGaD
Ponatinib—KDR—central nervous system—restless legs syndrome	0.00624	0.00828	CbGeAlD
Ponatinib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00615	0.0341	CbGpPWpGaD
Ponatinib—TEK—brain—restless legs syndrome	0.00606	0.00804	CbGeAlD
Ponatinib—ABL1—spinal cord—restless legs syndrome	0.00593	0.00787	CbGeAlD
Ponatinib—FGFR4—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.0059	0.0327	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00584	0.0324	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00583	0.0324	CbGpPWpGaD
Ponatinib—KIT—nervous system—restless legs syndrome	0.00574	0.00762	CbGeAlD
Ponatinib—KIT—central nervous system—restless legs syndrome	0.00553	0.00734	CbGeAlD
Ponatinib—PDGFRA—brain—restless legs syndrome	0.00549	0.00729	CbGeAlD
Ponatinib—SRC—brain—restless legs syndrome	0.00539	0.00714	CbGeAlD
Ponatinib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.00505	0.028	CbGpPWpGaD
Ponatinib—ABL1—nervous system—restless legs syndrome	0.005	0.00663	CbGeAlD
Ponatinib—KDR—brain—restless legs syndrome	0.00495	0.00657	CbGeAlD
Ponatinib—ABL1—central nervous system—restless legs syndrome	0.00481	0.00639	CbGeAlD
Ponatinib—RET—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.00475	0.0263	CbGpPWpGaD
Ponatinib—FGFR4—Signaling by NGF—MAP2K5—restless legs syndrome	0.00454	0.0252	CbGpPWpGaD
Ponatinib—KIT—brain—restless legs syndrome	0.00439	0.00582	CbGeAlD
Ponatinib—FGFR3—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00436	0.0242	CbGpPWpGaD
Ponatinib—CYP2D6—brainstem—restless legs syndrome	0.00413	0.00547	CbGeAlD
Ponatinib—KDR—Focal Adhesion—MAP2K5—restless legs syndrome	0.00405	0.0225	CbGpPWpGaD
Ponatinib—ABL1—brain—restless legs syndrome	0.00382	0.00507	CbGeAlD
Ponatinib—ABCG2—spinal cord—restless legs syndrome	0.00374	0.00496	CbGeAlD
Ponatinib—SRC—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00373	0.0207	CbGpPWpGaD
Ponatinib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.00365	0.0203	CbGpPWpGaD
Ponatinib—SRC—EPHB forward signaling—TF—restless legs syndrome	0.00361	0.02	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by NGF—MAP2K5—restless legs syndrome	0.00336	0.0186	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00329	0.0183	CbGpPWpGaD
Ponatinib—SRC—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00318	0.0177	CbGpPWpGaD
Ponatinib—SRC—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00306	0.017	CbGpPWpGaD
Ponatinib—FGFR2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.003	0.0167	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.00298	0.0165	CbGpPWpGaD
Ponatinib—ABL1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00297	0.0165	CbGpPWpGaD
Ponatinib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00295	0.0164	CbGpPWpGaD
Ponatinib—FGFR1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.0028	0.0155	CbGpPWpGaD
Ponatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00279	0.0155	CbGpPWpGaD
Ponatinib—SRC—Syndecan-3-mediated signaling events—POMC—restless legs syndrome	0.00273	0.0151	CbGpPWpGaD
Ponatinib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.00259	0.0144	CbGpPWpGaD
Ponatinib—CYP2C8—brain—restless legs syndrome	0.00248	0.00329	CbGeAlD
Ponatinib—ABCG2—brain—restless legs syndrome	0.00241	0.0032	CbGeAlD
Ponatinib—SRC—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00238	0.0132	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00231	0.0128	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.00227	0.0126	CbGpPWpGaD
Ponatinib—CYP3A4—nervous system—restless legs syndrome	0.0022	0.00291	CbGeAlD
Ponatinib—SRC—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00216	0.012	CbGpPWpGaD
Ponatinib—CYP2D6—nervous system—restless legs syndrome	0.00216	0.00287	CbGeAlD
Ponatinib—FGFR1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00215	0.0119	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.00215	0.0119	CbGpPWpGaD
Ponatinib—CYP3A4—central nervous system—restless legs syndrome	0.00212	0.00281	CbGeAlD
Ponatinib—CYP2D6—central nervous system—restless legs syndrome	0.00208	0.00276	CbGeAlD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00202	0.0112	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—MAP2K5—restless legs syndrome	0.0019	0.0106	CbGpPWpGaD
Ponatinib—ABCB1—spinal cord—restless legs syndrome	0.00185	0.00245	CbGeAlD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00179	0.00991	CbGpPWpGaD
Ponatinib—CYP2D6—brain—restless legs syndrome	0.00165	0.00219	CbGeAlD
Ponatinib—TEK—Hemostasis—TF—restless legs syndrome	0.00165	0.00916	CbGpPWpGaD
Ponatinib—ABCB1—nervous system—restless legs syndrome	0.00156	0.00206	CbGeAlD
Ponatinib—LCK—Signaling by NGF—MAP2K5—restless legs syndrome	0.00155	0.00861	CbGpPWpGaD
Ponatinib—ABCB1—central nervous system—restless legs syndrome	0.0015	0.00199	CbGeAlD
Ponatinib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.0014	0.00778	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MAP2K5—restless legs syndrome	0.00138	0.00768	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—MAP2K5—restless legs syndrome	0.00137	0.00762	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00124	0.00689	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00119	0.0066	CbGpPWpGaD
Ponatinib—ABCB1—brain—restless legs syndrome	0.00119	0.00158	CbGeAlD
Ponatinib—LCK—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00102	0.00565	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MAP2K5—restless legs syndrome	0.000974	0.00541	CbGpPWpGaD
Ponatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000924	0.00513	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.000901	0.005	CbGpPWpGaD
Ponatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.0008	0.00444	CbGpPWpGaD
Ponatinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000749	0.00416	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MAP2K5—restless legs syndrome	0.000721	0.004	CbGpPWpGaD
Ponatinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000657	0.00365	CbGpPWpGaD
Ponatinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000648	0.0036	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.000643	0.00357	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TF—restless legs syndrome	0.00064	0.00355	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TF—restless legs syndrome	0.000637	0.00354	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MAP2K5—restless legs syndrome	0.000628	0.00348	CbGpPWpGaD
Ponatinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000532	0.00296	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TF—restless legs syndrome	0.000525	0.00291	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000496	0.00275	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	0.000487	0.0027	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TF—restless legs syndrome	0.000464	0.00258	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000462	0.00256	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	0.000461	0.00256	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	0.00044	0.00244	CbGpPWpGaD
Ponatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000429	0.00238	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MAP2K5—restless legs syndrome	0.000406	0.00226	CbGpPWpGaD
Ponatinib—CYP3A5—Biological oxidations—POMC—restless legs syndrome	0.000398	0.00221	CbGpPWpGaD
Ponatinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000348	0.00193	CbGpPWpGaD
Ponatinib—CYP2C8—Biological oxidations—POMC—restless legs syndrome	0.000344	0.00191	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—POMC—restless legs syndrome	0.00034	0.00189	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MAP2K5—restless legs syndrome	0.000333	0.00185	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000322	0.00179	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MAP2K5—restless legs syndrome	0.000295	0.00164	CbGpPWpGaD
Ponatinib—CYP2D6—Biological oxidations—POMC—restless legs syndrome	0.000283	0.00157	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—POMC—restless legs syndrome	0.00024	0.00133	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000238	0.00132	CbGpPWpGaD
Ponatinib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	0.000185	0.00103	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—POMC—restless legs syndrome	0.000177	0.000984	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—POMC—restless legs syndrome	0.000154	0.000857	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—POMC—restless legs syndrome	0.000144	0.000797	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000132	0.000734	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—POMC—restless legs syndrome	0.000122	0.000677	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—POMC—restless legs syndrome	0.00012	0.000665	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—POMC—restless legs syndrome	0.000114	0.000631	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	0.000113	0.000629	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—POMC—restless legs syndrome	0.0001	0.000555	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—POMC—restless legs syndrome	9.49e-05	0.000527	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—POMC—restless legs syndrome	8.19e-05	0.000455	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—restless legs syndrome	7.25e-05	0.000403	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—restless legs syndrome	6.8e-05	0.000378	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—restless legs syndrome	5.89e-05	0.000327	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—restless legs syndrome	5.13e-05	0.000285	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—restless legs syndrome	4.84e-05	0.000268	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—restless legs syndrome	3.16e-05	0.000176	CbGpPWpGaD
